Jesduvroq vs. Aranesp: How do they compare?
Jesduvroq and Aranesp are both used to raise hemoglobin levels and to treat anemia associated with chronic kidney disease (CKD). However, they differ in their active ingredients, indications, ways of working in the body, routes, frequency of administration, side effect profiles, and warnings. Neither Jesduvroq nor Aranesp have been proven to improve quality of life, tiredness (fatigue), or well-being.
What is the difference in active ingredients between Jesduvroq and Aranesp?
Jesduvroq is the brand (trade) name for daprodustat, which belongs to the class of medicines called hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI).
Aranesp is the brand(trade) name for darbepoetin alfa, which is a recombinant human erythropoietin (a man-made version of the naturally occurring human hormone, erythropoietin).
What are Jesduvroq and Aranesp used to treat?
Jesduvroq is approved to treat anemia due to CKD in adults who have been receiving dialysis for at least four months. It should not be used in patients who are NOT on dialysis nor as a substitute for a blood transfusion in patients requiring an immediate correction of their anemia.
Aranesp is approved to treat anemia due to CKD in patients on dialysis and patients not on dialysis.
It may also be used to treat anemia due to concomitant myelosuppressive chemotherapy, in patients with a minimum of two additional months of planned chemotherapy.
What is the mechanism of action of Jesduvroq and Aranesp?
Jesduvroq acts on an enzyme called hypoxia-inducible factor prolyl hydroxylase (HIF-PH). This stimulates the release of erythropoietin which naturally occurs when oxygen levels are low. Erythropoietin is a hormone that increases the production of red blood cells, thereby reducing the symptoms of anemia. Jesduvroq is currently the only oral HIF-PHI inhibitor approved in the United States.
Aranesp acts like our naturally occurring (endogenous) erythropoietin to stimulate erythropoiesis, which is the process of red blood cell production. Endogenous erythropoietin is secreted by the interstitial cells in our kidneys when oxygen levels are low. It protects red blood cells from destruction and at the same time, stimulates stem cells of the bone marrow to increase the production of red blood cells.
Related questions
- Is omeprazole (Prilosec) bad for your kidneys?
- How long does it take for Farxiga to work?
- Can Farxiga cause kidney damage?
What are the differences in the way Jesduvroq and Aranesp are administered?
Jesduvroq is a once-daily oral tablet that is taken by mouth. It can be taken with or without food, and supplements such as iron or phosphate binders can be taken at the same time.
Aranesp is an injection that can be given subcutaneously (under the skin) or by IV infusion, once every one to four weeks. A healthcare provider usually administers it initially but they can teach you how to administer subsequent injections subcutaneously yourself at home.
What are the differences in side effects between way Jesduvroq and Aranesp?
The most common side effects of Jesduvroq are high blood pressure, thrombotic vascular events (such as blood clots, myocardial infarction, and stroke), and abdominal pain. Dizziness and hypersensitivity reactions were also common. It carries a black-boxed warning for an increased risk of death, myocardial infarction, venous thromboembolism, and thrombosis of vascular access. Hemoglobin levels greater than 11 g/dL are expected to further increase this risk, but no trial has identified a hemoglobin target level, dose of Jesduvroq, or dosing strategy that does not increase these risks. The lowest dose of Jesduvroq should be used which is sufficient to reduce the need for red blood cell transfusions.
The most common side effects of Aranesp are high blood pressure, shortness of breath, edema in the legs, cough, procedural low blood pressure, angina, and rash. It also carries a black-boxed warning for an increased risk of death, myocardial infarction, venous thromboembolism, and thrombosis of vascular access. Hemoglobin levels greater than 11 g/dL are expected to further increase this risk, but no trial has identified a hemoglobin target level, dose of Aranesp, or dosing strategy that does not increase these risks. The lowest dose of Aranesp should be used which is sufficient to reduce the need for red blood cell transfusions.
References
- Aranesp (darbepoetin alfa) Product Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103951orig1s5173_103951orig1s5258lbl.pdf
- Jesduvroq (daprodustat) Product Information. https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Jesduvroq/pdf/JESDUVROQ-PI-MG.PDF#nameddest=MG
Read next
How does Jardiance help with heart failure?
Jardiance may help with heart failure by improving your heart’s ability to pump blood throughout the body and deliver oxygen to tissues and organs. It may do this by reducing sodium and fluid retention, improving energy use by the heart, reducing inflammation and preventing or reversing cardiac enlargement. Continue reading
What is Farxiga used for and how does it work?
Farxiga (dapagliflozin) is used to treat certain adults with type 2 diabetes mellitus, heart failure and chronic kidney disease.
Farxiga is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It also works by reducing the increased activity of the sympathetic nervous system that contributes to the progression of heart failure and the increased intraglomerular pressure that contributes to CKD. Continue reading
When should I take Kerendia?
You will take Kerendia tablets once daily by mouth with or without food. If you are unable to swallow the tablets whole tablets, you may crush them and mix with water or soft foods such as applesauce right before you take it. Your healthcare provider will determine the correct dose for you based on your kidney function, and may increase your dose after 4 weeks. Continue reading
Related medical questions
- Does Kerendia lower blood pressure?
- What is Rayaldee used for?
- What are the risks for severe COVID-19?
- What is the difference between Retacrit and Procrit?
- What is the difference between Retacrit and Epogen?
- How does Korsuva work?
Drug information
Related support groups
- Darbepoetin Alfa (1 questions, 5 members)
- Daprodustat (1 questions, 3 members)
- Aranesp (1 questions, 17 members)
- Jesduvroq (1 questions, 3 members)
- Chronic Kidney Disease (27 questions, 103 members)
- Anemia Associated with Chronic Renal Failure (4 questions, 9 members)
- Hemodialysis (2 questions, 13 members)
- Peritoneal dialysis (2 questions, 25 members)